What is the ticker symbol for Lumos Pharma?

Lumos Pharma trades under the ticker LUMO on NASDAQ.

What sector does Lumos Pharma operate in?

Lumos Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LUMO in a portfolio?

PortView shows LUMO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Lumos Pharma (LUMO) Stock Analysis

NASDAQHealthcareBiotechnology

$4.34+0.00%

1-year price historyRange $1.45 – $4.45

52-week range$4.34

$1.37$4.58

What Lumos Pharma does

Lumos Pharma, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to advancing and commercializing medical treatments for rare conditions. Their principal therapeutic compound, LUM-201, an orally administered growth hormone secretagogue called ibutamoren, is currently undergoing Phase 2 clinical evaluation. This drug candidate is being investigated for its potential in treating pediatric growth hormone deficiency and various other uncommon endocrine conditions. The company's operations are based in Austin, Texas.

Key metrics

Market cap

$37.54M

P/E (TTM)

-1.01

EPS (TTM)

$-4.28

Beta

0.33

Dividend yield

0.00%

Revenue / share

$0.25

50-day avg

$4.23

200-day avg

$3.10

52-week high

$4.58

52-week low

$1.37

CEO

Richard J. Hawkins

ETFs linked to LUMO

Broad-market and Healthcare sector ETFs an investor holding Lumos Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how LUMO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LUMO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Lumos Pharma?: Lumos Pharma trades under the ticker LUMO on NASDAQ.
Which exchange is LUMO listed on?: LUMO is listed on NASDAQ.
What sector does Lumos Pharma operate in?: Lumos Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze LUMO in a portfolio?: PortView shows LUMO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.